Skip to main navigation Skip to search Skip to main content

Effect of Vascular Access Strategy on Long-Term Outcomes in Patients with Out-of-hospital Cardiac Arrest A Randomised Clinical Trial

Mikael Fink Vallentin, Mathias J Holmberg, Asger Granfeldt, Thomas Lass Klitgaard, Søren Mikkelsen, Fredrik Folke, Helle Collatz Christensen, Amalie Ling Povlsen, Alberthe Hjort Petersen, Sofie Winther, Lea Wildt Frilund, Carsten Meilandt, Kristian Blumensaadt Winther, Allan Bach, Thomas H Dissing, Christian Juhl Terkelsen, Steffen Christensen, Line Kirkegaard Rasmussen, Lone Riis Mortensen, Thomas ElkmannAnders Gunnar Nielsen, Charlotte Runge, Elise Klæstrup, Jimmy Højberg Holm, Mikkel Bak, Lars-Gustav Rahbek Nielsen, Mette Pedersen, Gunhild Kjærgaard-Andersen, Peter Martin Hansen, Anne Craveiro Brøchner, Erika Frischknecht Christensen, Frederik Mølgaard Nielsen, Christian Gade Nissen, Jeppe Waldstrøm Bjørn, Peter Burholt, Laust E R Obling, Sarah Louise Duus Holle, Lene Russell, Henrik Alstrøm, Søren Hestad, Jens Ulrik Hove Buciek, Karina Jakobsen, Mette Krag, Michael Sandgaard, Birthe Sindberg, Lars W Andersen*

*Corresponding author for this work

Abstract

OBJECTIVE: The Intravenous versus Intraosseous Vascular Access for Out-of-Hospital Cardiac Arrest (IVIO) trial was a randomised clinical trial that investigated initial vascular access strategy for out-of-hospital cardiac arrest. The current manuscript presents outcomes at 6 months and 1 year.

METHODS: Adults with non-traumatic out-of-hospital cardiac arrest, in whom vascular access was indicated, were randomised to initial intraosseous or intravenous access. The allocated method was attempted up to two times. Prespecified 6-months and 1-year outcomes included survival, survival with a favourable neurological outcome, defined as a modified Rankin Scale score of 0-3, and health-related quality-of-life assessed using the EuroQoL 5-Dimension 5-Level questionnaire on domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.

RESULTS: Of the 1479 patients included in the main manuscript primary analyses, three were lost to follow-up for 1-year survival. At 1 year, 82 patients (11%) in the intraosseous group and 68 patients (9%) in the intravenous group were alive (risk ratio 1.24; 95% confidence interval 0.91-1.67). Survival with a favourable neurological outcome was observed in 76 patients (10%) and 61 patients (8%), respectively (risk ratio 1.28; 95% confidence interval 0.93-1.77). Among survivors, the mean EQ-5D-5L numeric score was 83 in the intraosseous group and 76 in the intravenous group (mean difference 7; 95% confidence interval 1-13).

CONCLUSION: Long-term outcomes were similar between patients who received initial intraosseous versus intravenous vascular access during adult out-of-hospital cardiac arrest. These findings do not support a difference in patient outcomes between the two vascular access strategies.

TRIAL REGISTRATION: EU Clinical Trials number 2022-500744-38-00; ClinicalTrials.gov number NCT05205031.

Original languageEnglish
Article number111087
JournalResuscitation
Volume223
ISSN0300-9572
DOIs
Publication statusPublished - 2026

Keywords

  • Advanced life support
  • Cardiac arrest
  • Clinical trial
  • Vascular access

Fingerprint

Dive into the research topics of 'Effect of Vascular Access Strategy on Long-Term Outcomes in Patients with Out-of-hospital Cardiac Arrest A Randomised Clinical Trial'. Together they form a unique fingerprint.

Cite this